ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.020
+0.040 (2.02%)
At close: Jan 2, 2026, 4:00 PM EST
2.050
+0.030 (1.49%)
After-hours: Jan 2, 2026, 7:57 PM EST
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $1.99 billion as of January 2, 2026. Its market cap has decreased by -5.06% in one year.
Market Cap
1.99B
Enterprise Value
2.59B
1-Year Change
-5.06%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $1.99B, a decrease of -86.58%. That is a compound annual growth rate of -34.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | 14.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |